N/A
N=31
Community Walking Trials: Comparing Prosthetic Feet
Lower Extremity Amputation
Bottom Line
View on ClinicalTrials.gov: NCT03703232 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Difference Between Investigational Foot and Usual Foot in the Prosthetic Evaluation Questionnaire (PEQ): Ambulation Sub-Scale — 4.2 score on a scale — p=0.092
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Investigational prosthetic foot (Device)
- Age
- Pediatric, Adult, Older Adult · 16+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Jun 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Difference Between Investigational Foot and Usual Foot in the Prosthetic Evaluation Questionnaire (PEQ): Ambulation Sub-Scale |
4.2 | 0.092 |
| PRIMARY Difference Between Investigational Foot and Usual Foot in the Comprehensive Lower Extremity Amputee Socket Survey (CLASS): Comfort Scale |
1.1 | 0.760 |
| PRIMARY Difference Between Investigational Foot and Usual Foot in the Figure-of-8 Walking Test: Time |
-0.53 | 0.007 sig |
| PRIMARY Difference Between Investigational Foot and Usual Foot in the Daily Activity Log: Scale Measuring How Prosthesis Helps or Hinders When Walking on a Challenging Surface |
10.5 | 0.003 sig |
| SECONDARY Difference Between Investigational Foot and Usual Foot in the Prosthetic Evaluation Questionnaire (PEQ): Residual Limb Health Subscale |
1.6 | 0.861 |
| SECONDARY Difference Between Investigational Foot and Usual Foot in the Comprehensive Lower Extremity Amputee Socket Survey (CLASS): Stability Subscale |
3.2 | — |
| SECONDARY Difference Between Investigational Foot and Usual Foot in the Narrowing Beam Walking Test: Distance Travelled |
0.45 | 0.405 |
| SECONDARY Difference Between Investigational Foot and Usual Foot in the Daily Activity Log: Balance Confidence |
-0.2 | 0.798 |
| SECONDARY Difference Between Investigational Foot and Usual Foot in the Prosthetic Evaluation Questionnaire (PEQ): Utility Subscale |
4.2 | 0.382 |
| SECONDARY Difference Between Investigational Foot and Usual Foot in the Prosthetic Evaluation Questionnaire (PEQ): Sound Subscale |
-8.9 | 0.179 |
| SECONDARY Difference Between Investigational Foot and Usual Foot in the Comprehensive Lower Extremity Amputee Socket Survey (CLASS): Suspension Subscales |
0.2 | 0.984 |
Summary
The purpose of the study is to obtain performance measurements and participant feedback about use of an investigational prosthetic foot compared to the participant's usual prosthetic foot. To accomplish this, the study will use a combination of laboratory motion analysis, functional tests, and community mobility trials where participants complete questionnaires and interviews about use of an investigational prosthetic foot compared to the participant's usual prosthetic foot.
Individuals with amputations that participate in the (optional) motion analysis sub-study at the University of Washington will complete forward walking, side-step, and across river rock with usual foot (session 1), and also with the investigational foot locked and unlocked (session 2) after an accommodation period of between 1-4 weeks. The participants will rate their experiences using socket comfort score and the socket pressure score.
Control participants recruited at the University of Washington to provide information about performance for people without amputation will go through the consenting process, then will be asked to complete forward walking, Figure-of-8 Walk Test, Narrowing Beam Walking Test, side-step, and walking across river rock surface. These tests will be conducted at a single session.
Eligibility Criteria
Inclusion Criteria
- Unilateral below knee amputation, use a prosthetic foot for at least 1 year
- Ability to walk 400 meters on level ground without using a walking aid and without an increase in pain
- Ability to read, write, and comprehend English
Exclusion Criteria
- Residual skin breakdown
- Weight over 300 lbs
Data sourced from ClinicalTrials.gov (NCT03703232). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.